Bristol-Myers Drug Cocktail Stymies Melanoma Tumors

Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.